Mandate

Vinge advises on the sale of Fiomi Diagnostics AB

March 05, 2012

Vinge has advised the shareholders of Fiomi Diagnostics AB in connection with the sale of the shares in the company to Trinity Biotech plc, which is quoted on NASDAQ. Fiomi, which is based in Uppsala, develops platforms for point-of-care diagnostics based on a technology which originated from Uppsala Åmice AB.

Vinge’s team consisted of partner Johan Winnerblad together with, among others, associates Claes Henriksson and Louise Markgren as well as project assistants Ida Norlin

Related

Vinge has advised Consolid on the establishment of Consolid Equity III

The fund held its final closing on June 2, 2025, having secured commitments from a diverse investor base that includes several leading institutional investors from Europe and North America, as well as established fund-of-funds. The fundraising was highly successful, with the fund significantly oversubscribed. Consolid Equity III has more than doubled its total commitments compared to its predecessor fund.
July 02, 2025

Vinge advises EQT VIII in connection with the divestment of Recover to Pangea AS

Recover is a leading Scandinavian property remediation specialist. Following EQT’s acquisition in 2020, Recover has invested in its digital capabilities while divesting non-core business units to sharpen focus on water, fire and other core property remediation services.
July 02, 2025

Vinge advises XPartners on its issuance of senior secured bonds

Vinge advises XPartners Samhällsbyggnad AB (“XPartners”) in connection with its SEK 3 billion issuance of senior secured bonds
July 02, 2025